[HTML][HTML] The signal pathways and treatment of cytokine storm in COVID-19
L Yang, X Xie, Z Tu, J Fu, D Xu, Y Zhou - Signal transduction and …, 2021 - nature.com
Abstract The Coronavirus Disease 2019 (COVID-19) pandemic has become a global crisis
and is more devastating than any other previous infectious disease. It has affected a …
and is more devastating than any other previous infectious disease. It has affected a …
[HTML][HTML] Cytokine storm in COVID-19: the current evidence and treatment strategies
Y Tang, J Liu, D Zhang, Z Xu, J Ji, C Wen - Frontiers in immunology, 2020 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) is the pathogen that causes
coronavirus disease 2019 (COVID-19). As of 25 May 2020, the outbreak of COVID-19 has …
coronavirus disease 2019 (COVID-19). As of 25 May 2020, the outbreak of COVID-19 has …
Surviving sepsis campaign guidelines on the management of adults with coronavirus disease 2019 (COVID-19) in the ICU: first update
W Alhazzani, L Evans, F Alshamsi, MH Møller… - Critical care …, 2021 - journals.lww.com
BACKGROUND: The coronavirus disease 2019 pandemic continues to affect millions
worldwide. Given the rapidly growing evidence base, we implemented a living guideline …
worldwide. Given the rapidly growing evidence base, we implemented a living guideline …
[HTML][HTML] Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is a new human disease with few effective …
syndrome coronavirus 2 (SARS-CoV-2), is a new human disease with few effective …
Convalescent plasma as a potential therapy for COVID-19
L Chen, J Xiong, L Bao, Y Shi - The Lancet infectious diseases, 2020 - thelancet.com
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which
originated in Wuhan, China, has become a major concern all over the world. The …
originated in Wuhan, China, has become a major concern all over the world. The …
Hyperimmune immunoglobulin for people with COVID‐19
V Piechotta, C Iannizzi, I Monsef… - Cochrane Database …, 2023 - cochranelibrary.com
Background Hyperimmune immunoglobulin (hIVIG) contains polyclonal antibodies, which
can be prepared from large amounts of pooled convalescent plasma or prepared from …
can be prepared from large amounts of pooled convalescent plasma or prepared from …
[HTML][HTML] Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)
Background The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
the cause of a rapidly spreading illness, Coronavirus Disease 2019 (COVID-19), affecting …
the cause of a rapidly spreading illness, Coronavirus Disease 2019 (COVID-19), affecting …
[HTML][HTML] Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective
Y Yang, MS Islam, J Wang, Y Li… - International journal of …, 2020 - ncbi.nlm.nih.gov
Abstract Currently, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2,
formerly known as 2019-nCoV, the causative pathogen of Coronavirus Disease 2019 …
formerly known as 2019-nCoV, the causative pathogen of Coronavirus Disease 2019 …
Compounds with therapeutic potential against novel respiratory 2019 coronavirus
MA Martinez - Antimicrobial agents and chemotherapy, 2020 - Am Soc Microbiol
Currently, the expansion of the novel human respiratory coronavirus (known as SARS-CoV-
2 [severe acute respiratory syndrome coronavirus 2], COVID-2019 [coronavirus disease …
2 [severe acute respiratory syndrome coronavirus 2], COVID-2019 [coronavirus disease …
[HTML][HTML] Convalescent plasma in Covid-19: Possible mechanisms of action
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible of the
coronavirus disease 2019 (COVID-19) pandemic. Therapeutic options including …
coronavirus disease 2019 (COVID-19) pandemic. Therapeutic options including …